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Introduction
1The HIV epidemic of India arouses a great epidemiological interest.
India accounts for roughly half of Asia’s HIV prevalence and has the third
largest number of people living with HIV/AIDS [1].  Although HIV prevalence
is high among sex workers and drug users, clients of sex workers are the most
powerful driving force in India’s HIV epidemics and constitute the largest
infected population group in the country. As per National behavioural
surveillance survey in 2006, 2.4 percent of adult males i.e., around 73.5 lakh
adult males have visited commercial sex workers during the year prior to the
survey. These men then transmit the infection to their wives and they form
transmission bridge from the high risk group to the general population.
According to 2010 report of the Joint United Nations Program on
HIV/AIDS (UNAIDS), more than 90 percent of infected women have
acquired the virus from their husbands or intimate partners.[1] In most cases,
women are at an increased risk not due to their own sexual behaviour, but
because their partner is an IDU or also has FSWs or MSM as other sex
partners[2]. The factors that are likely to influence HIV transmission among
married couples are poorly studied and need to be clearly established.
Based on the serological status couples can be
Seroconcordant couple
Both partner are on same HIV status either they are HIV positive or
negative
2Serodiscordant couple
Couple in which one partner is HIV positive other is HIV negative,
having different serostatus
HIV negative individuals in discordant partnerships are at a high risk
of acquiring infection and preventive interventions targeted at such
individuals are urgently needed. This study is carried out to assess the
prevalence of HIV among such low risk women and to identify the risk
factors that favor HIV transmission among married couples, so that
serodiscordance can be identified and counselled accordingly.
Review of
Literature
3Introduction
It is now 25 years since acquired immune deficiency syndrome (AIDS)
was first recognized as a novel disease. Within 2 years of defining AIDS as a
distinctive syndrome in 1981, the human immunodeficiency virus (HIV) was
identified as the causative agent. HIV infection is acquired sexually, from
blood or blood products, or vertically from an infected mother during
pregnancy, birth or breastfeeding. The virus infects immunocompetent cells
including CD4 T cells and macrophages. It creates variable patterns of disease
in individuals, groups and races but all are characterized by evolving,
sometimes fulminant immunodysfunction (AIDS) affecting many systems of
the body.
HIV IN INDIA
HIV epidemic has been evolving in the country since the first case was
detected in Tamil Nadu in 1986[4]. In 2009 the National AIDS Control
Organization (NACO) of the government of India has estimated that around
2.4 million people were living with HIV with a prevalence of 0.3%.[3] Of
these, an estimated 39% are female and 3.5% are children.[3]
According to the 2010 UNGASS HIV country report, India’s epidemic
is concentrated within most-at-risk-populations (MARPs), with prevalence
substantially higher among these populations than in the general population.
Prevalence also varies dramatically by district, state, and region, with
4numerous isolated pockets of high prevalence. Approximately 60 percent of
people living with HIV/AIDS (PLWHA) live in the six high-prevalence
states. The high prevalence states includes Andhra Pradesh, Tamil Nadu, and
Maharashtra and in the North eastern states of Nagaland and Manipur.
WAVES OF HIV EPIDEMIC
HIV epidemics spread classically in 3 waves.[5]
? The first wave is seen amongst the sex workers and the IDUs who
form the core transmitters or the core groups.
? The second wave reaches the clients of the core transmitters group.
The HIV infection is brought to the low risk population from the core
transmitters group through the bridge population. The bridge
population is used to connote the mobile population such as truck
drivers, single male migrants etc.
? When the spouses, children and relatives of the clients of sex workers
get affected the third wave is completed.
? Recently a fourth wave constituted by the adolescents has also been
proposed.
5HIV VIROLOGY
Human immunodeficiency virus (HIV)
HIV is a retrovirus belonging to the subfamily of lentivirus. There are
two main types of HIV: HIV1 and HIV 2. HIV 1 and 2 have originated from
the Simian immunodeficiency virus (SIV) probably from the once found in
chimpanzees (SIVcpz) and in sooty mangabey monkeys (SIVsm). HIV is a
lymphocytotropic and neutrotrophic virus. Therefore it may be found in
almost all the body fluids and organs. It is present in infective discharges in
semen, vaginal, cervical secretions and blood.
HIV-1 contains a single-stranded RNA genome that is 9 kilobases in
length and contains 9 genes that encode 15 different proteins.[6] The major
viral proteins (some of which contain >1 protein subunit) are classified as
structural proteins (Gag, Pol, and Env), regulatory proteins (Tat and Rev), and
accessory proteins (Vpu, Vpr, Vif, and Nef).[7]
Differences between HIV1 and HIV2[8]
Character HIV1 HIV2
Prevalence Globally Africa
Virulence Highly infective Less infective
Mother to child transmission High(24.7%) Low(1.2%)
Incubation period Shorter compared to HIV2 longer
6Structure of HIV virus
HIV-1 subtypes
Three major classes of HIV-1 have emerged: M (major), N (new), and
O (outlier). Among M group viruses, which account for >90% of HIV
infections worldwide, there are 9 subtypes, called clades, designated by the
letters A-D, F-H, J, and K, as well as many recombinant form[9][10]. Variation
between one clade and another in the amino acid sequences of the envelope
protein may exceed 30%. As seen in the map the viral diversity is greatest in
sub-Saharan Africa.
7Due to the increased occurrence of mutations in the viral population an
infected individual is likely to have swarm virus variants (Quasi species).
According to phylogenetic studies most of the HIV1 strains belong to subtype
C in India. The predominant HIV1 subtype in US and Europe is subtype B
whereas HIV E and B are common in Thailand. A new recombinant HIV
between C and A has been reported from Pune.[11]
Pathogenesis
Entry to the cell
HIV enters macrophages and CD4+ T cells by the adsorption of
glycoproteins gp160  on its surface to receptors ( either CCR5 or CXCR4) on
the target cell followed by fusion of the viral envelope with the cell
membrane and the release of the HIV capsid into the cell.[12][13] gp120 binds to
integrin ?4?7 activating LFA-1 the central integrin involved in the
establishment of virological synapses, which facilitate efficient cell-to-cell
spreading of HIV-1.
Viral replication
Shortly after the viral capsid enters the cell, an enzyme called reverse
transcriptase liberates the single-stranded (+)RNA genome which copies it
into a complementary DNA (cDNA) molecule.[14]The process of reverse
transcription is extremely error-prone, and the resulting mutations may cause
drug resistance or allow the virus to evade the body's immune system. The
8reverse transcriptase also has ribonuclease activity as well as DNA-dependent
DNA polymerase activity.[15] Newly synthesised complement form a double-
stranded viral DNA that is then transported into the cell nucleus. The
integration of the viral DNA into the host cell's genome is carried out by
another viral enzyme called integrase
Viral assembly and release
The final step of the viral cycle, assembly of new HIV-1 virons, the
env polyprotein (gp160) goes through the endoplasmic reticulum where it is
cleaved by protease and processed into the two HIV envelope glycoproteins
gp41 and gp120[16]. These are transported to the plasma membrane of the host
cell where gp41 anchors the gp120 to the membrane of the infected cell. The
Gag (p55) and Gag-Pol (p160) polyproteins also associate with the inner
surface of the plasma membrane along with the HIV genomic RNA as the
forming virion begins to bud from the host cell. During maturation, HIV
proteases cleave the polyproteins into individual functional HIV proteins and
enzymes. The various structural components then assemble to produce a
mature HIV virion. The mature virus is then able to infect another cell
ROUTES OF TRANSMISSION
Sexual route
The primary method of spread of HIV infection worldwide is through
sexual exposure. In the areas of highest HIV prevalence globally,
9heterosexual intercourse is the primary mode of transmission, accounting for
approximately 70% of the overall sexual transmission.[17] In the United States
and Europe, acquisition of the virus through homosexual contact remains
important, and there is some evidence of increasing incidence of infection
among young gay men and ethnic minorities.[18]
HIV has been isolated from blood, seminal fluid, pre-ejaculate, vaginal
secretions, cerebrospinal fluid, saliva, tears, and breast milk of infected
individuals.[19][20]In genital fluids, HIV may be found in both cell-free and
cell-associated compartments, but it is unknown which is responsible for
productive infection.[21] Viral concentrations in tears and saliva are
comparatively low, and there are substances in saliva that appear to inhibit
infectivity. No cases of HIV infection have been documented to arise from
contact with non-bloody saliva or tears. Female-to-female HIV transmission
has been reported, but is rare.[22] Serum HIV viral load is strongly associated
with heterosexual transmission between HIV-serodiscordant African sexual
partners, where transmission was noted to be rare at viral loads <1,500
copies/ml.[23]
Nonsexual HIV transmission
Nonsexual HIV transmission can occur through transfusion with
contaminated blood products, injection drug use, occupational exposure, or
accidental needle sticks. The risk from occupational needle sticks to health
care workers from known HIV-positive source patients in case series
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performed prior to the availability of potent ART was found to be 0.33-
0.5%.[24] Factors increasing the risk of HIV acquisition from an occupational
needle stick include deep injury, injury with a visibly bloody device, or injury
with a device that had been previously used in the source patient's vein or
artery.[25]
Mother to child transmission (MTCT)
The risk of transmission of HIV from pregnant mother to child is
between 21 and 43% in developing countries.[26] The transmission of the virus
from the mother to the child can occur in utero (during pregnancy),
intrapartum (at childbirth), or via breast feeding[27]
In utero  Intrapartum  Breast feeding
% of mother to child
transmission
10 to 15% 50 to 70% 10to 15%
In a study conducted in Malawi  the HIV incidence in breastfed infants
between 1 and 5 months is higher (0.7% per month) when compared to that
between  6 and 11 months (0.6% per month) and 12 and 17 months ( 0.3% per
month)[28]. However now it is shown that exclusive breast feeding is better
than mixed feeding.[29]
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Interplay of Factors Driving Sexual Transmission
Duration of infectiousness
Lack of cure and long duration of infectiousness are the characteristics
of HIV that distinguishes it from other STIs. The long asymptomatic period
associated with HIV infection puts many of the contacts at higher risk of
acquiring the infection.
Risk of infection per contact
The average risk of acquiring HIV infection per exposure through
various route is given below. Among sexual exposure, Anal sex caries the
highest risk, especially for the receptive partner.
Exposure Route Estimated infections
per 10,000 exposures to
an infected source
Blood transfusion 9,000 (90%)[31]
Mother-to-child, including pregnancy, childbirth
and breastfeeding (without treatment)
2,500 (25%)[32]
Mother-to-child, including pregnancy, childbirth
and breastfeeding (with optimal treatment)
100–200 (1%–2%)[32]
Needle-sharing injection drug use 67 (0.67%)[33]
Percutaneous needle stick 30 (0.30%)[34]
Receptive anal intercourse (2009 and 2010
studies)
 [30–890][35] 143 [48–
285][30]
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Insertive anal intercourse for uncircumcised men
(2010 study)
62 (0.62%)[7–168][30]
Insertive anal intercourse for circumcised men
(2010 study)
11 (0.11%) [2–24][30]
Low-income country female-to-male 38 (0.38%) [13–110][35]
Low-income country male-to-female 30 (0.3%) [14–63][35]
Receptive (female) penile-vaginal intercourse 10 (0.1%)[36][37]
Insertive (male) penile-vaginal intercourse 5 (0.05%)[36][37]
Fellating a man 1 (0.01%)[37]
Man being fellated 0.5 (0.005%)[37]
The per contact risk of HIV transmission with a commercial or a casual
partner is likely to be less than for other STDs example gonorrhoea. The risk
of infection per contact is not the same every time and it depends on the
following:[5]
? Concordance of the HIV status among the couples
? Stage of HIV infection
? Untreated  associated STIs
? Use of barrier methods
? Male circumcision
? Sexual behaviours and practices
Behavioural and social factors [5]
? little or no condom use
? large number of adult population with multiple sex partners
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? large sexual networks—people moving back and forth between
home and place of work
? age mixing typically between old men and young women
? Women’s economic dependence robs them of their control over
their right to have safer sex.
Biological factors
? High rates of STIs  especially those causing genital ulceration and
low rates of male circumcision
? High viral loads- high levels during the initial infected stage and
again during the later stages
Bridge population
The bridge population is constituted by those who have sex with both
high risk and low risk partners. The bridge behaviour involves transmission of
HIV across sub-population having different risk behaviours. Studies have
shown that MSMs having sex with both commercial and non commercial sex
partners play a major role in the transmission of HIV. [5]
Vulnerability of women to HIV
Women are biologically more susceptible than men to HIV infection.
Male to female transmission is 2-4 times more efficient than female to male
transmission and this is because [5]
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? Females have larger mucosal surface exposed during sexual
intercourse.
? Another reason is that of higher concentration of HIV in semen than in
vaginal fluids.[42]
? Many STIs in women are asymptomatic than men, so there is delay in
seeking medical help
? Stigma of attending an STI clinic is more attached with women than in
men.
? Women are also exposed to the risk of blood products transfusion due
to their childbearing role.
? women’s inability to negotiate safe sex practises with their partners
make women more vulnerable to HIV infection.
? Men’s unwillingness to use condoms further accentuates women’s risk.
In a study of the prevalence of and risk factors for HIV infections in
TamilNadu (1994-1995) only 2% of married men were found to use
condoms.[5]
Socioeconomic consequences
             People with lower literacy and from poor families have higher risk of
HIV.[43]  For people already living in poverty, further income loss can threaten
their ability to meet basic needs such as food.[44] Poverty also forces people to
accept choices that put them at risk for HIV infection. Studies reveal that poor
women are forced into sex work and into providing sexual favors in return for
money, and to be less able to insist on condom use. [45]
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Role of condoms in transmission of HIV
According to the Centers for Disease Control & Prevention (CDC), a
number of carefully conducted studies, employing rigorous methods and
measures, have demonstrated that consistent condom use is highly effective in
preventing HIV transmission.[38][39]
? In a two-year study of serodiscordant couples no uninfected partner
became infected among couples using condoms correctly and
consistently at every act of vaginal or anal sex versus 10 percent of
those using condoms inconsistently.[38][40]
? In a similar two-year study, two percent of uninfected partners who
used condoms consistently became HIV-infected versus 12 percent
among those who used condoms inconsistently or not at all.[38]
?  Increased use of condoms in casual relationships is important in
Uganda's declining HIV infection rates.[41]
Male circumcision and HIV
Male circumcision is de?ned as the surgical removal of all or part of
the foreskin of the penis and may be practiced as part of a religious ritual, as a
medical procedure, or as part of a traditional ritual performed as an initiation
into manhood. There is strong evidence that medical male circumcision
reduces the acquisition of HIV by heterosexual men by between 38% and
66% over 24 months. Inclusion of male circumcision into current HIV
prevention measures guidelines is warranted by the UNAIDS and the WHO in
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2007.[46] Researchers have noted that the inner aspect of the foreskin is well
supplied with Langerhans cells and that in vitro, HIV-1 demonstrates a
speci?c tropism for these cells, in particular the CD4 receptors on them.
According to this theory, circumcision would remove the potential entry site
for HIV; however, in direct contradiction to the above theory, the inner
prepuce contains apocrine glands which secrete lysozyme. Lysozyme
reportedly kills HIV-1 in vitro, suggesting a protective effect of the
foreskin. [46]
CLASSIFICATION OF HIV DISEASE
HIV damages the immune system, leaving the infected person
vulnerable to a variety of infections called "opportunistic" infections. The
effect of HIV on the immune system is monitored by measuring the CD4
(helper) lymphocyte count in the blood. A normal CD4 count is
approximately between 600 and 1,200 cells/µL. CD4 counts <500 cells/µL
indicate that impairment of immune function is present, and are an indication
for ART. CD4 counts <200 cells/µL indicate imminent risk of serious OIs or
other complications of HIV disease, and prompt treatment is
recommended.[47]
The World Health Organization has developed a clinical staging
system for HIV infection.[48]This system relies more heavily on clinical rather
than laboratory evaluation, and has been used widely in resource-constrained
areas where laboratory testing is not widely available.
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Table 3: WHO Staging System for HIV Infection and Disease in Adults
and Adolescents (a)
Clinical stage I
1. Asymptomatic
2. Persistent generalized lymphadenopathy
Performance scale 1: asymptomatic, normal activity
Clinical stage II
1. Weight loss, <10% of body weight
2. Minor mucocutaneous manifestations (seborrheic dermatitis, prurigo,
fungal nail infections, recurrent oral ulcerations, angular cheilitis)
3. Herpes zoster within the last 5 years
4. Recurrent upper respiratory tract infections (i.e., bacterial sinusitis)
And/or performance scale 2: symptomatic, normal activity
Clinical stage III
1. Weight loss, >10% of body weight
2. Unexplained chronic diarrhoea, >1 month
3. Unexplained prolonged fever (intermittent or constant), >1 month
4. Oral candidiasis (thrush)
5. Oral hairy leukoplakia
6. Pulmonary tuberculosis within the past year
7. Severe bacterial infections (i.e., pneumonia, pyomyositis)
And/or performance scale 3: bedridden <50% of the day during the last
month
Clinical stage IV
1. HIV wasting syndrome, as defined by the U.S. Centers for Disease
Control and Prevention (CDC)
2. Pneumocystis jiroveci (formerly carinii) pneumonia
3. Toxoplasmosis of the brain
4. Cryptosporidiosis with diarrhoea >1 month
18
5. Cryptococcosis, extrapulmonary
6. Cytomegalovirus disease of an organ other than liver, spleen, or lymph
nodes
7. Herpes simplex virus infection, mucocutaneous >1 month, or visceral
any duration
8. Progressive multifocal leukoencephalopathy
9. Any disseminated endemic mycosis (ie, histoplasmosis,
coccidioidomycosis)
10. Candidiasis of the oesophagus, trachea, bronchi, or lungs
11. Atypical mycobacteriosis, disseminated
12. Nontyphoid Salmonella septicemia
13. Extrapulmonary tuberculosis
14. Lymphoma
15. Kaposi sarcoma
16. HIV encephalopathy, as defined by the CDC
And/or performance scale 4: bedridden >50% of the day during the last
month
NATURAL HISTORY OF UNTREATED HIV INFECTION
Acute retroviral syndrome
The acute viral syndrome of primary HIV infection (sometimes
referred to as "seroconversion illness") was first defined in 1985, with
symptoms resembling those of mononucleosis appearing within 2 to 4 weeks
following exposure to HIV.[49][50] The most common presenting symptom is
fever, seen in over 75% of patients.[51] Other common symptoms include
lymphadenopathy, headache, rash, joint pains, night sweats, and mucosal
candidiasis and pharyngitis.[52] The neurological features include
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meningoencephalitis, peripheral neuropathy, facial palsy, Guillian-Barre
syndrome, cognitive impairment and psychosis. The non-specific symptoms
of primary HIV infection may make diagnosis a challenge and therefore
requires a high index of clinical suspicion. Routine HIV antibody testing may
be negative for several weeks or even months after exposure in the so-called
"window period.".[53]
During primary infection with HIV, plasma viral load often reaches
very high levels in the range of millions of RNA copies/mL. [54][55] Thus, for
individuals in whom primary HIV infection is clinically suspected, HIV RNA
assays, which have a sensitivity approaching 100% and specificity of 97.4%
in this setting, and positive RNA tests during acute infection should be
confirmed by documentation of subsequent HIV antibody conversion.[56]
Aggressive ART during acute retroviral illness protects activated HIV
specific CD4 cells from HIV infection to preserve a response analogous to the
response seen in non-progressors. [57]
Asymptomatic HIV infection
After the period of acute HIV infection during which CD4 counts and
viral load change dramatically and a relative equilibrium between viral
replication and the host immune response is reached, and individuals may
have little or no clinical manifestations of HIV infection except persistent
generalised lymphadenopathy (PGL). PGL is defined as enlarged lymph
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nodes (>1cm) involving at least two non contiguous site, other than inguinal
nodes, in absence of an obvious cause.[58] This time between initial infection
and the development of AIDS may be long, averaging 10 years, even in the
absence of treatment.[59]
Symptomatic HIV disease
During the relative clinical latency the viral replication and the CD4
count turnover remains active with most affected individuals having a disease
progression due to the increased loss of CD4 cell counts (by 50-90 cells/µL
per year in asymptomatic individuals) and a perturbation of the host immune
system.[60][61]  The rate of progression of infection may vary considerably.
During early symptomatic HIV infection, the skin and mucous
membranes are predominantly involved. Constitutional symptoms include
unexplained fever, weight loss, recurrent diarrhoea, fatigue and malaise.
Widespread seborrheic dermatitis, folliculitis, recurrent herpes simplex
infection, oral candidiasis, oral hairy leukoplakia and herpes zoster are most
common presentation.
Late symptomatic stage is characterised by risk of developing
opportunistic infections. Common conditions are Pneumocystis carinii
pneumonia, toxoplasmosis, disseminated Mycobacterium avium complex
infection, oesophageal candidiasis and related malignancies.
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Clinical AIDS
According to CDC criteria, AIDS is defined by either diagnosis of one
of the AIDS-defining conditions, or by measurement of CD4 levels <200
cells/µL. This stage is characterised by AIDS defining infections and
malignancies. Some of more frequently seen infections are CMV,
cryptococcal meningitis, histoplasmosis and cervical dysplasia. CNS
involvement is very prominent: AIDS dementia, CNS lymphoma and CMV
infections. Survival time from the development of AIDS varies according to
the AIDS-defining event. The mean survival time after diagnosis of AIDS in
the United States prior to the availability of antiretroviral treatment was 10-12
months.[62]
Long-term non progressors(LTNPs)
A small subset of individuals infected with HIV--probably <5%--
remain free of symptoms, achieve good control of HIV viral replication, and
maintain high CD4 counts in the absence of antiretroviral medications over
many years of infection, (98) In general, LTNPs appear to have strong cellular
immune responses to a variety of HIV antigens.[64][65]
INTERACTION BETWEEN HIV AND STIs
The complex interaction between STIs and HIV has been demonstrated
in many epidemiological, in vitro and clinical studies over the last many
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years. STDs could facilitate HIV 1 transmission by increasing the
infectiousness of the index case, the susceptibility of the partner or both.
STIs As a cofactor for HIV transmission
Both ulcerative and non-ulcerative STIs promote HIV transmission by
augmenting HIV infectiousness and HIV susceptibility via different biological
mechanisms.
Effect of ulcerative STIs on HIV transmission
Lack of mechanical skin or mucous membrane barrier makes easy viral
entry due to ulcertation or microulceration.[66]
Sexually transmitted infection which usually present as genital
ulceration includes
Syphilis (Treponema pallidum)
Chancroid (Haemophilus ducreyi )
Granuloma inguinale (klebsiella granulomatis)
Lymphogranuloma venerum (Chlamydia trachomatis)
Genital herpes ( Herpes simplex virus)
Method by which genital ulcer diseases favors HIV transmission
? Among HIV-seronegative individuals, genital ulcers may increase the
susceptibility to HIV by disrupting mucosal and skin integrity
? Increasing the presence and activation of HIV susceptible cells in
genital tract (the susceptibility cofactor effect).[67]
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? Haemophilus ducreyi, for example, evokes a cell-mediated immune
response which attracts HIV susceptible cells to the ulcer surface. In
fact, H.ducreyi may contain specific T cell-stimulating antigens which
further predispose T cells to infection by HIV.[67]
? viral STDs such as herpes interact in the genital tract, which promotes
the establishment of HIV infection. For example, in tissues coinfected
with HSV-1, the virions are able to infect keratinocytes despite the lack
of CD4 receptors. In gaining access to the cells, HIV may also take
advantage of changes in cellular chemokine receptors that had resulted
from infection with other viruses, as shown in recent studies of
cytomegalovirus.[67]
? Genital ulcers bleed frequently during sexual intercourse, resulting in a
potential-increase in HIV infectiousness (the infectivity cofactor
effect).
? The presence of HIV in genital ulcer exudates in HIV infected
individuals confirmed by culture and PCR (the infectivity cofactor
effect).[68]
? Increased number of HIV-containing white blood cells in both
ulcerative and inflammatory genital secretions (the infectivity cofactor
effect).
? Increasing HIV replication by certain ulcerative STD pathogens
(e.g.Treponema pallidum lipoproteins) and increasing the number of
receptors expressed pp-cell receptive to HIV 1 (e.g. H. ducreyi lipo-
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oligosaccharide may increase the CCR5 receptors on a macrophage
cell line)[67]
Effect of urethritis on HIV transmission
Urethritis is defined as infection-induced inflammation of the urethra.
STD causes of urethritis are categorized as either
? gonococcal urethritis (ie, due to infections with Neisseria gonorrhoeae)
? NGU (ie, due to infections with following organism)
? Chlamydia trachomatis,
? Ureaplasma urealyticum,
? Mycoplasma hominis, Mycoplasma genitalium,
? Trichomonas vaginalis
Rare infectious causes of urethritis include
? lymphogranuloma venereum, herpes genitalis, syphilis, streptococcal,
staphylococci and anaerobes.
causes increased shedding of HIV virus in the genital tract (the
infectivity cofactor effect), probably by recruiting HIV infected
inflammatory cells as part of the normal host response. Investigators
have noted a significant increase in the detection of HIV 1 DNA in
cervicovaginal fluids of patients with gonorrhoea and chlamydial
infection.[69]
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Association between STDs and HIV Infection[67]
STDs Increased Risk for
HIV Acquisition
Clinical
exacerbation
N+ gonorrhoeae infection +/- 3 to 5 times +/-
Chlamydial infection + 3 to 5 times +/-
Trichomonas vaginalis infection + 3 to 5 times -
Bacterial vaginosis + 2 to 5 times -
Chancroid + 2 to 5 times +
Syphilis + 3 to 9 times +
Genital herpes + 2 times +
Granuloma inguinale + +/-
Human Papilloma infection + +
LGV + +/-
Hepatitis B - +
Role of cervicitis in HIV transmission
Sexually transmitted diseases (STDs) that can cause cervicitis include:
? Chlamydia
? Gonorrhea
? Herpes virus (genital herpes)
? Human papilloma virus (genital warts)
? Trichomoniasis
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For cervicitis specifically, three potential mechanisms have been
suggested to explain the observed relationship of cervicitis and HIV infection.
a. Recruitment of inflammatory cells to the cervical mucosa may result in
increase concentration of HIV infected CD4 lymphocytes-
macrophages.
b. In the presence of an inflammatory milieu, HIV replication is
enhanced, perhaps through the generation of reactive oxygen products
secreted by granulocytes and secondary to cell activation which is
mediated by inflammatory cytokines (interleukin-1 or tumour necrosis
factor alpha).[67]
c. Cervicitis is associated with micro-ulceration and friable mucosal
tissue that provides a portal of exit or entry for virus or infected cells.
Bacterial vaginosis and HIV transmission
Bacterial vaginosis (BV) is polymicrobial syndrome involving the
replacement of normal vaginal flora lactobacilli by a wide variety of the
anaerobic bacteria and mycoplasmas. It requires a special mention since it is a
common vaginal infection in women, and the relative risk of transmission of
HIV is 2 to 5 times in the presence of BV. Schmid et al have summarized all
possible mechanisms from research studies of different workers:[67]
? Lactobacilli produce lactic acid that maintains vaginal pH and inhibits
the growth of many organisms, including those associated with BV.
Some lactobacilli particularly those posted against the development of
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BV produce hydrogen peroxide which is toxic to a number of
organisms including HIV.[70]
? Low vaginal pH may inhibit CD4 lymphocyte activation and,
therefore, decrease HIV target cells in the vagina. Therefore, a high
vaginal pH due to the presence of BV may make the vagina more
conducive to HIV survival and adherence.[70]
? BV has also been shown to increase the intravaginal levels of
interleukin-10, which increases the susceptibility macrophages to HIV.
? A heat-stable protein elaborated by Gardnerella vaginalis increase
production of HIV by as much as 77 fold.[67]
? Mycoplasma hominis is the potent inducer of HIV 1 expression among
several vaginal bacterial species studied.[67]
Role of Trichomonas vaginalis in HIV transmission
Trichomonas may amplify HIV-1 transmission by increasing
susceptibility in an HIV-1-negative person and the infectiousness in an HIV-
1-positive patient. The biological rationale for this is compelling:
? The natural history of this organism, including its often symptomless
nature and protracted carriage, may also contribute to increasing HIV-1
transmission.
? T. vaginalis isolates are cytotoxic to urogenital epithelial cells.[71]
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? The organism typically elicits an aggressive local cellular immune
response, with heavy infiltration of leucocytes, even in symptom-free
patients.
? About 50% of infected women have punctate haemorrhages which can
be observed on colposcopy.[72]
Thus in an HIV-1-negative person, it can enlarge the portal of entry for
HIV-1 by increasing the number of HIV-1 target cells available and viral
access to the bloodstream. In an HIV-1-infected patient, the leucocyte
infiltration and haemorrhages induced by trichomonas may expand the portal
of exit and increase shedding of HIV-1 in the genital area. [73]
Effect of genital candidiasis on HIV transmission
C. albicans causes vaginal inflammation that may compromise the
integrity of the vaginal mucosa. Vaginal inflammation usually results after
Candida hyphae overcome the normal bacterial vaginal flora and invade the
epithelium. The body responds by recruiting polymorphonuclear leukocytes
to kill Candida. [74]
Presence of vulvovaginal candidiasis is associated with an increase in
the number of copies of cell-associated and cell-free HIV-1 RNA in women
who are seropositive for HIV. [75]
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Role of HPV on HIV transmission
Human papillomavirus (HPV) infection, one of the very common STIs,
presents as genital warts to carcinoma in HIV-positive patients.
? The local immune response elicited by HPV infection predisposes to
HIV acquisition, and that individual in the process of clearing an HPV
infection might be at increased risk. Thus risk of acquiring infection
increase with the increasing numbers of concurrent HPV infections,
and HPV infections clearance.[76]
? Enhanced friability and inflammation of the cervix from HPV disease
or infection
? The anal lesions caused by HPV bring blood vessels closer to the
surface in the anus and make the lining of the anus thinner and more
fragile.[77]
Effects of STD management on HIV Transmission
In a study conducted in Malawi the results showed that HIV 1 positive
men with urethritis had eight times higher HIV-1 concentrations in seminal
plasma than that in seropostive men without urethritis. After treatment, the
concentration of HIV 1 RNA in semen decreased significantly. Ghys and co-
workers found a significant increase of HIV 1 DNA in Cervicovaginal lavage
samples from patients with gonorrhoea Chlamydia infection, Cervicovaginal
ulcer or cervical mucopus. A week after STI treatment, the detection of HIV 1
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in these secretions decreased from 42 to 21%; however changes in detection
rate were not observed in women whose STIs were not cured. [67]
A compelling body of evidence shows that prevention, early diagnosis
and treatment of STDs can be important in a HIV prevention strategy. This is
particularly true when treatment of symptomatic STIs is addressed.
LABORATORY TESTING OF HIV
HIV antibody testing
HIV infection is usually diagnosed by testing serum for antibodies to
HIV using a commercially available enzyme-linked immunosorbent assay
(ELISA or EIA). Because the ELISA test is not entirely specific, positive
results are confirmed with a Western blot assay, which identifies antibodies to
specific components of HIV.[78][79] An infected individual may test ELISA
negative during a "window period" that varies in length from a few weeks to a
few months after infection. Newer methodologies allow antibody testing on
saliva and urine specimens ,[80][81] although positive results should be
confirmed with serologic testing. Rapid HIV serum testing, with results
available in 3-30 minutes, has shown 99-100% sensitivity and specificity
compared to ELISA when tested in clinical settings.[82]
Laboratory tests for the diagnosis of HIV infection
A person suspected to harbour HIV infection may be investigated for
the with the following investigative modalities such as:[83]
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1. Tests for HIV specific antibodies in serum/plasma
? Screening tests
? ELISA
? Rapid test
? Supplemental tests
? Western blot assay
? Immunofluorescence test
? Line immunoassay
? Confirmatory test
? Virus isolation
? Detection of HIV specific core antigen (p24)
? Polymerase chain reaction (RT PCR/b-DNA)
2. Tests for HIV specific antibodies in the saliva
3. Tests for HIV specific antibodies in the urine
Enzyme-Linked Immunosorbent Assays/Enzyme Immunoassays
ELISA is the most commonly used type of test to screen for HIV
infection because of its relatively simple methodology, inherent high
sensitivity, and suitability for testing large numbers of samples, particularly in
blood testing centers.[84]
A common feature of all varieties of ELISA is the use of enzyme
conjugates that bind to specific HIV antibody and substrates/chromogens that
produce colour in a reaction catalyzed by the bound enzyme conjugate.
Various types of ELISA includes
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? Indirect ELISA
? Competitive ELISA
? Sandwich ELISA
Indirect ELISA
This the most popular method of ELISA in which HIV antigen is
attached to a well of a 96-well microtiter plate. Antibody in the sample is
allowed to react with the antigen-coated solid support, usually for 30 minutes
at 37º C or 40º C. After a wash step to remove unbound serum components,
addition of a conjugate (an antihuman immunoglobulin with a bound enzyme)
binds to the specific antibody that is attached to the antigens on the solid
phase. Following another wash, addition of an appropriate substrate results in
colour development that is detected by a spectrophotometer.[85]
Rapid tests
These tests have a total reaction time of less than 30 minutes, so they are
best for emergency clinics, casualties and trauma clinics. Various
technologies on which rapid tests are based includes [86]
1. Immunoconcentration (dot blot assay)
2. Immunochromatography (lateral flow assay)
3. Particle agglutination (latex, gelatin, RBCs)
4. Immunocomb (dip stick/comb test) (mostly ELISA based)
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CD4 testing
The CD4 cell count in blood correlates with the risk of OIs in HIV
disease, [87] and is therefore a useful marker for HIV disease staging. The
CDC recommends CD4 testing every 3-6 months in all HIV-infected persons.
Additionally, an inversion of the normal CD4/CD8 cell ratio, which is usually
>1 in non-HIV-infected individuals is usually seen. In resource-limited
settings where CD4 count may be unavailable, the total lymphocyte count
(TLC), which can be determined simply and cheaply, may be used as a
surrogate for CD4 in determining stage of HIV infection.[86] For example, in a
cohort of HIV-positive people in south India, a TLC of <1,400 cells/µL has
been shown to be a good predictor of a CD4 count <200 cells/µL and thus an
appropriate surrogate marker for initiating cotrimoxazole prophylaxis. TLC
may also have applications in monitoring response to antiretroviral therapy in
place of or in conjunction with CD4 count. [89]
Preexposure prophylaxis
PrEP could substantially reduce HIV transmission in high-risk
populations in the United States. The combination of tenofovir and
emtricitabine (TDF/FTC) shows promise as pre-exposure prophylaxis (PrEP)
for persons at high risk of HIV infection. Trials of TDF/FTC-based
chemoprophylaxis in macaques report nearly 8-fold reductions in the risk of
HIV infection.[90] In humans, recent observations in high-risk women suggest
an efficacy estimate of 65%.[91] Others have noted that PrEP poses risks for
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additional drug toxicity, viral resistance, and behavioural disinhibition.[90]
However, the long-term impact of PrEP on transmission, behaviour, clinical
in outcomes, and cost has not been studied.  Given recent disappointments
HIV prevention and vaccine development, further study of PrEP-based HIV
prevention is warranted. [91]
Now trials were conducted in using preexposure prophylaxis in
serodiscordant couples to prevent HIV transmission. [92]
Aim of the Study and
Materials& Methods
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Aim
Aim of the study / objectives of the study
? To study the prevalence of both HIV seropositive concordance and
discordance among  couples attending Institute of Venereology using
rapid method.
? To study epidemiological characters of HIV infected couples
? To identify the factors that are likely to influence HIV transmission
among married couples.
? To study the pattern of sexually transmitted infections among both
concordant and discordant HIV infected couples.
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Materials & Methods
Study design
Cross sectional study.
Sample:
100 HIV patients and their married partners attending Institute of
Venereology from November 2010 to November 2011 are randomly recruited
for the study.
Inclusion Criteria:
? HIV seropositive individual and their married partner attending
Institute of Venereology.
Exclusion criteria:
? HIV infected individual who is not willing to disclose their personal
history or not willing to bring their partner.
? High risk group such as commercial sex workers, transgenders.
Methods:
HIV seropositive index case and their partner are interviewed at
outpatient department in privacy and in confidential manner. A structural
questionnaire is administered to the patient after getting signed consent. The
questionnaire includes questions related to demographic characters, sexual
behaviours and history of previous sexually transmitted infections. In sexual
history the patients were asked about homosexual, bisexual behaviour, sexual
practice, premarital, extramarital contact and condom usage. The history of
presenting complaints, past STIs’ and their treatment are recorded.
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The clinical staging of HIV seropositive index cases done after medical
examination, based on World Health Organization (WHO) clinical staging of
HIV. Physical and genital examination done to find out any genital or extra
genital evidence of STI’s.
The STIs’ in these patients are diagnosed with clinical findings and
relevant lab investigations.
In case of genital ulcers
Dark field examination for Treponema pallidum
Tzanck test for giant multi nucleated epithelial cells.
Gram stain for Haemophilus ducreyi and Candida
Tissue smear and Leishman’s stain for klebsiella granulomatis
10% KOH examination
In case of urethral discharge or burning micturition
Gram stain examination of urethral smear for gonococci.
Urethral swab or urine for gonococcal culture.
Urine culture using Cled media.
Vaginal discharge of all female patients examined for :
Wet mount microscopy for Trichomonas vaginalis.
10% KOH preparation for Candida albicans.
Gram stain of vaginal smear for clue cells and  Candidal hyphae.
Gram stain of endocervical smear for gonococci.
In addition to above investigation endocervial swab for gonococcal
culture are collected for all female patients.
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Blood samples were collected for performance of the serological tests,
which includes
HIV Rapid Method (strategies 3)
VDRL if positive confirmed by TPHA
The result of HIV are given only after post test counselling.
Observations
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Results
Data collected is analysed using Chi-square, the statistical significance
was considered if P value < 0.05.
Serostatus of the couples with respect to HIV
A total of 100 HIV seropositive individuals and their married partners
were examined in this study. Among the 100 married couples 65 couples were
seroconcordant for HIV (both husband and wife were positive) whereas 35
couples were serodiscordant for HIV(either husband or wife is positive).
Table. 5. Serostatus of the couples
Serostatus No. Of couples Percentage
Seroconcordance 65 65%
Serodiscordance 35 35%
Total 100 100%
? Among that 35 HIV serodiscordant couples, males alone positive in 29
couples and females alone positive in 6 couples.
? Among 100 males 94 were positive for HIV.
?  Among 100 females 71 females were positive for HIV.
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Fig. 1. Serostatus of the couples
Fig 2 HIV reactivity in males and females
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1) Evaluation of epidemiological factors of HIV infected couples:
a) Age distribution among study couples
A total of 100 married couples which includes 100 males and 100
females were recruited for this study. The age distributions among them were
as follows:
Table1.Age distribution among the couples
Age
group
Total number of
males
Total number of
females
percentage
18-25 1 14 7.5
26-35 29 37 33
36-45 45 39 42
46-55 19 10 14.5
56-65 6 0 3
Total 100 100 100
b) Area of residence
Most of the couples were from urban areas which constituted 68% and
the rural inhabitants constituted about 32%.
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Fig.3. Age distribution among study couples
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c) Educational status
In the study population majority of the males had an educational status
which lie between 6th to 12th standard whereas majority of the females were
illiterate.
Table. 2. Educational status
Educational
status
Number of
males
Number of
females
Total  percentage
illiterate 16 41 28.5%
<5th std 24 18 21%
5th -12th std 56 38 47%
Graduate 4 3 3.5%
Total 100 100 100%
d)Monthly income
In this study, majority of the couples (67%) had a monthly income in
the range of Rs. 2000 to 5000. About 33% of the couples had a low income of
about 2000 or below. None of our patients had a monthly income greater than
Rs.5000.
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Fig. 5. Educational status
Fig. 6. Monthly income
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e) High risk behaviours
Majority males and few females of our study population had history of
high risk sexual behaviours. We studied them under the broad divisions under
the heading contacts with commercial sex workers, homosexuals, and any
known person. The data is tabulated is as follows:
Table. 3. High risk behaviours
High risk behaviours High risk sexual behaviour
( sexual contact other than
married partner)
percentage
Males Females male female
Commercial sex
workers (CSW)
84 0 84% 0
Homosexuals 9 0 9% 0
Known person 7 6 7% 6%
Denies history 8 94 8% 94%
Total 100 100
A larger proportion of the males (84%) had high risk sexual behaviours
both before and after marriage with the commercial sex workers. 9% of them
had history of contact with homosexuals. Only 6% of the females had history
of sexual contact with person other than their married partner .
f) Possible routes of HIV acquisition in index cases
In this study 90% of the couples had a heterosexual orientation while
8% were bisexual. Two of the couples denied high risk behaviour  and had
history of blood transfusion.
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                                 Fig. 7. High risk behaviours
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g) Reason for HIV testing in index cases
Among the index cases 92 were males and 8 were females. The
reasons for HIV screening was studied under the following headings and the
observations were as follows:
Table. 4. Reason for HIV testing in index cases
Reason for HIV testing in index cases Males Females
High risk behaviour 10 Nil
Presence of STI 18 2
Antenatal screening Nil 2
Referred from other departments 64 4
Total 92 8
Fig. 9. Reason for HIV testing in index cases
0
10
20
30
40
50
60
70
High risk
behaviour Presence of
STI Antenatal
screening Referred
from other
departments
10 18
0
64
0
2
2
4
Females
Males
48
2)  EVALUATION OF THE VARIOUS RISK FACTORS IN
RELATION TO THE HIV SEROCONCORDANCE AND
SERODISCORDANCE OF THE COUPLES
a) Duration of marital contact
The number of years that a couple was together after they got married
was studied under the following range groups namely <5 years, 5 to 10 years,
11 to 15 years and >15 years. The proportion of couples who were
seroconcordant increased with the increase in their years together they spent
after marriage but the proportion was statistically insignificant.
Table. 6. Duration of marital contact
Married since Frequency Outcome Total
Discordance Concordance
<5 years 19 9(47.4%) 10(52.6%) 19
5 to 10 years 31 11(35.5%) 20(64.5%) 31
11 to 15 years 22 8(36.4%) 14(63.6%) 22
>15 years 28 7(25.0%) 21(75.0%) 28
Total 100 35 65 100
The statistical analysis by Pearson’s Chi squared test is p value is
0.470 (>0.05).
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b) Number of sexual contacts per week
? 12 of the study couples had around <=1 sexual contact per week with
their partner. Of these couples 3 were seroconcordant and 9 were
serodiscordant.
? 75 of the couples had 2 to 3 sexual contacts per week. Among that 51
couples were seroconcordant and the remaining 24 were
serodiscordant.
? 13 couples had >=4 times sexual contact per week with their sexual
partners. Among that 11 couples were seroconcordant and the
remaining 2 were serodiscordant.
Table.7. Number of sexual contacts per week
Sexual contacts per week Frequency
Outcome
Total
Discordance Concordance
<=1 12 9(75.0%) 3(25.0%) 12
2 to 3 75 24(32.0%) 51(68.0%) 75
>=4 13 2(15.4%) 11(84.6%) 13
Total 100 35 65 100
The data was statistically insignificant after analysis by Pearson’s
Chi-Square p value is 0.404 (>0.05)
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Fig. 10 Duration of marital contact
Fig. 11. Number of sexual contacts per week
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C) HIV staging
The HIV staging was done according to the WHO classification. For
statistical analysis the stages 1 and 2 were considered together as early and
stage 3 and 4 as late. They were then together compared with the serostatus
data.
Table.8. HIV staging
HIV Stage
grouping
Frequency
Outcome
Total
Serodiscordance Seroconcordance
Early (1+2) 71 32(54.9%) 39(45.1%) 71
Late  (3+4) 29 3(10.3%) 26(89.7%) 29
Total 100 35 65 100
The statistical analysis by continuity correction was significant p value
is <0.05
Fig. 12. HIV stage grouping
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d) Patients under ART
Among all the 100 couples only 12 were under ART, while two of the
couples were defaulters. Of the 12 couples who were under the treatment 6
were seroconcordant and 6 were serodiscordant.
Table. 9. Patients under ART
ART Frequency
Outcome
Total
Discordance Concordance
No 88 29(33.7%) 57(66.3%) 88
Yes 12 6(50%) 6(50%) 12
Total 100 35 65 100
The statistical analysis by continuity correction is p value is 0.517
(>0.05)
Fig. 13. Patients under ART
serodiscordance
seroconcordant
0
10
20
30
40
50
60
No
Yes
29
6
57
8
serodiscordance
seroconcordant
53
e) Condom usage
Most of the study population (74%) have never used condom during
their sexual acts. 23% of the couples used condom occasionally whereas 3%
were unaware about the usefulness of condom.
Table. 10. Condom usage
Condom usage Frequency
Outcome
Total
Discordance Concordance
No 77 17(22.1%) 60(77.9%) 77
Yes 23 18(78.3%) 5(21.7%) 23
Total 100 35 65 100
The statistical analysis by continuity correction is p value is <0.05
Fig. 14. Condom usage
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f) Role of circumcision
In this study 7 males had underwent circumcision  whereas the rest of
the population [93] had not been circumcised. Of the 7 males with
circumcision 1 was seroconcordant and 6 were serodiscordant.
Table. 11. Role of circumcision
Circumcision Frequency                    Outcome Total
Discordance Concordance
No 93 29(31.2%) 64(68.8%) 93
Yes 7 6(85.7%) 1(14.3%) 7
Total 100 35 65 100
The statistical analysis by continuity correction is p <0.05 (0.012)
Fig. 15. Role of circumcision
g)  Practise of oral sex
All the patients in the study  denied having oral sex with their partners.
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h)  Practice of anal sex
Anal sex was practiced by about 35 of the study population whereas
65 of the couples denied the anal sexual practise. Out of those who practiced
anal sex 5 were serodiscordant and the remaining 30 were seroconcordant.
Table.12. Practise of anal sex
Anal sex Frequency                  Outcome Total
Discordance Concordance
No 60 34(56.7%) 26(43.3%) 60
Yes 40 1(2.5%) 39(97.5%) 40
Total 100 35 65 100
The statistical analysis by continuity correction is p value is
<0.05 (0.00).
Fig . 16. Practise of anal sex
0
10
20
30
40
50
60
who practised
who denied
39
26
1 34
serodiscordant
seroconcordant
56
i) Sex during menstruation
Thirty eight couples had a history of having sex during the menstrual
phase of their female partner among which 37 of them were seroconcordant
and 1 was serodiscordant.
Table. 13. Sex during menstruation
Sex during
menstruation
Frequency
Outcome
Total
Discordance Concordance
Yes 38 1(2.6%) 37(97.4%) 38
No 62 34(54.8%) 28(45.2%) 62
Total 100 35 65 100
The statistical analysis by continuity correction (2x2) table is p value is
<0.05
Fig. 17. Sex during menstruation
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3) Analysis of the presence of sexually transmitted diseases and its
relation to the HIV serostatus of the couples:
1)Previous venereal diseases (PVDs)
History of previous STIs were found in the following number of
patients:
Table. 14. Previous veneral diseases (PVDs)
PVDs HIV
seroconcordance
HIV
serodiscordance
Males Females Total
Genital
ulceration
17 2 16 3 19
Urethritis 5 1 6 0 6
Balanoposthitis 3 2 5 0 5
Vaginal
discharge
3 1 0 4 8
Total 31 6 27 7 38
Fig.18. Distribution of PVDs in the study population
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PVD in males
Among  the study population 27 males had a positive history of having
one of the listed veneral diseases whereas the remaining 73 males had a
negative history.
Table. 15. PVD in males
PVD males
Outcome
Total
Discordance Concordance
No 31(42.5%) 42(57.5%) 73
Yes 4(14.8%) 23(85.2%) 27
Total 35 65 100
The statistical analysis by continuity correction is significant p value is
<0.05
Fig. 19. PVD in males
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PVD in females
Among the study population 7 females had a positive history. The
remaining 93 females did not have any history of previous venereal diseases.
Table. 16
PVD wife Outcome Total
Serodiscordance Seroconcordance
No 34(36.6%) 59(63.4%) 93
Yes 1(14.3%) 6(85.7%) 7
Total 35 65 100
PVD in females
The statistical analysis by continuity correction was not significant p
value is >0.05
Fig. 20. PVD in females
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2) Sexually transmitted infections:
The occurrence of various sexually transmitted diseases diagnosed by
clinical and necessary lab investigations and was distributed as follows:
The most common STI in the males was genital ulcer disease whereas
in the females it was bacterial vaginosis.
Table.19. STIs distribution
STIs HIV
seroconcordance
HIV
serodiscordance
Males Females Total
VDRL
reactivity
12 4 9 7 16
Herpes genitalis 7 0 5 2 7
Ano-genital
wart
9 3 11 1 12
Non-specific
genital
ulceration
11 1 8 4 11
Non-specific
urethritis
7 2 9 0 8
Candidal
balanoposthitis
5 2 7 0 6
Vulvovaginal
candidiasis
7 2 0 9 9
Bacterial
vaginosis
11 3 0 14 14
Trichomonas
vaginalis
6 1 0 7 7
Cervicitis 8 1 0 9 9
Bartholin’s
abscess
0 1 0 1 1
Total 82 21 49 54 100
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Sexually transmitted infections in males:
Among the 40 males who had STIs, 9 males had mixed venereal
diseases.  Among that 8 males (88%)  belong to HIV seropositive concordant
while 1(12%) males were HIV seropositive discordant.
Table. 17. STI in males
STI in husbands Outcome Total
Seroconcordance Serodiscordance
Yes 33(82.5%) 7(17.5%) 40
No 35(58.3%) 25 (41.7%) 60
Total 68 32 100
Statistical analysis by continuity correction is significant p value is
<0.05
Fig. 21. STI in males
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e) STI in females
Sexually transmitted infection was present in 39 females whereas it
was absent in the remaining 61 females. Among the 39 females who had STIs
10 females had multiple venereal diseases.  9 among them belong to HIV
positive seroconcordant group while 1 belong to HIV seropositive discordant
group.
Table. 18. STI in females
STI females Outcome Total
Seroconcordance Serodiscordance
No 30(49.2%) 31(50.8%) 61
Yes 35(89.7%) 4(10.3%) 39
Total 65 35 100
The STIs in females were statistically significant by continuity
correction p value is <0.05
Fig. 22. STI in females
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Fig.23. STIs distribution
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Discussion
A hundred HIV patients and their married partners attending Institute
of Venereology, Madras Medical College were randomly recruited for this
study. All the patients were interviewed in privacy using a structured
questionnaire after getting their signed consent, and the data thus obtained
was tabulated and their statistical analysis is as follows:
Serostatus of the couples
In this study 65% of the couples were HIV positive seroconcordance
and 35% of the couples were HIV serodiscordant. Which was similar to study
conducted in Baroda[100] ( 72.4% were seroconcordance while 27.6%  were
serodiscordant). This shows the increase in transmission of HIV infection
through intimate sexual relationships. Majority of the index cases are males,
therefore females are vulnerable to new infections. So, prevention measures
should be targeted towards these population groups. [101]
Age distribution
The mean age of males and females in this study was 40.5 and 34 years
respectively. The total mean age was 37 years. The findings are similar to
those observed in the studies conducted in Kashmir.[93] Similar studies
conducted in Eastern India[94] had a mean age of 32.6 which is lower than this
study.  This observation can be attributed to this study population being only
married couples and the exclusion of the paediatric and the adolescent
population. In this study 75% belonged to the age group of 25 to 45 years and
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similar observations was found in the clinico-epidemiological study
conducted on HIV patients in Trivandrum. [95]
Area of residence
Most of the couples were from urban areas which constituted 68% and
the rural inhabitants constituted about 32%. This can be attributed to the low
awareness about HIV disease among the rural population. [96]
Educational status
In this study population majority of the males had an educational status
which lie between 6th to 12th standard whereas majority of the females
illiterate.  About 47% of all the study population had a secondary level of
education and 28.5% were illiterate. Only 3.5% of the population were
graduates. In a study conducted in rural areas of the Saurashtra region of
Gujarat, India it was found that the basic knowledge of HIV/AIDS is still
lacking in about two fifths of the rural population. Literacy and media
exposure are definitive factors that determine awareness of HIV among
them.[96]
Monthly income
In this study majority of the couples had a monthly income in the range
of Rs. 2000 to 5000. None of our patients had a monthly income greater than
Rs.5000. People with low literacy and poor family have higher risk of HIV.
Majority of these populations are in their productive age group and therefore
it affects the economic status of the family and also the country. [43]
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High risk behaviours
In this study 84% of the males give history of exposure to CSWs.
Several studies conducted in India show a similar finding. [97][98] Only 6% of
the female population had a positive history of high risk behaviour which
suggests that majority of the females acquire the infection mainly from their
husbands or intimate partners.[1] There were 7% of males with homosexual
activities and thereby serve as the bridge population in transmitting the
disease to their female partners.[5]
Modes of acquisition of HIV in the index cases
About 92% of the index cases acquired HIV through heterosexual
contacts whereas 8% were bisexuals and the remaining 2% had history of
blood transfusion. These findings correlate with many studies in the South
Indian region which confirm that heterosexuality to be the primary mode of
transmission.[99]
Reason for HIV testing in index cases
In relation to this study findings of more than 90% of the index cases
having history of high risk behaviour only 10% of them came for HIV
screening on the first hand. The same scenario was observed in those with
STIs (observed 40% in males and 39% in the females). This suggests the lack
of awareness and initiative among the population at risk towards HIV.[96]
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Married since and number of sexual contacts per week
Though statistically insignificant, the proportion of concordance
significantly increased across the category of number of years of marital
relationship and frequency of sexual contact per week. A cross sectional
studies conducted in Europe have corroborated similar finding.[102]
HIV staging
Advanced HIV disease (stage 3 and stage 4) were significantly
associated with seroconcordance of the couples. Similar findings have been
seen in various other cross sectional studies conducted in Zimbabwe and
Zambia.[103][104]  Anderson has also demonstrated that higher quantities of
viral particles are found in genital secretions of patients with advanced HIV
disease compared to asymptomatic patients.[106]
ART therapy
Various studies depicted initiation of ART therapy can prevent HIV
transmission from index case to partner. [103][106] In this study role of ART in
HIV transmission were not statistically significant.  This can be due to
? Only few patient were under ART in our study so the data can be too
low to calculate statistical significance.
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? Since it was the cross sectional studies we were not able place the
events properly i.e. HIV transmission between partners have occurred
before initiation of ART.
Anal sex and sex during menstruation
The practise of anal sex and sex during menstruation were statistically
significant in the seroconcordant group which is similar to the findings
observed in other studies. [102][106]
Condom usage
The proportion of condom usage was significantly high in
serodiscordant groups as compared to the seroconcordant group. The
protective effect of condom usage among serodiscordant couples have been
demonstrated in various studies. [35][40] Similar findings have also been
confirmed in the studies conducted by CDC, USA.[1]
Role of circumcision
Though the prevalence of circumcision was low (7%) this study
population, it was significantly associated with serodiscordancy.
Circumcision decreases the risk of achieving HIV infection in the
heterosexual group up to 8 times compared to the uncircumcised population.
This can be explained by a large number of Langerhans cells in the prepucial
skin which act as the target for HIV virus. [46] Further it also reduces the
likelihood of contracting STD, hence decreasing the chance of HIV
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transmission. Inclusion of male circumcision into the current HIV prevention
measure guidelines is warranted by the UNAIDS and the WHO in
2007(18).[46]
Previous venereal diseases
In this study 31% of the males and 11% of the females had a positive
history of PVDs. The association of PVDs and the seroconcordant rates in
males was statistical significant whereas it was not statistically significant in
the females. However, there was a significant increase in the proportion of
seroconcordance across the category of PVDs in the female population. A
study conducted in Europe also shows association of PVDs with sexual
transmission of HIV.[107] The statistical insignificance in the female
population could be attributed to the following reasons
? Very less number of females had a positive history
? PVDs in the females are relatively asymptomatic
? Social stigma more predominant among the female population
? Low educational status leading to unawareness among them
Sexually transmitted infections and HIV transmission
40 males had sexually transmitted infections at the time of clinical
examination. Among them 33 belonged to HIV seroconcordance group and
the remaining were HIV serodiscordant. Among that 9 of them had mixed
venereal diseases of which 8(88%) were HIV seroconcordant while 1(12%)
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males were HIV serodiscordant. Genital ulcer disease was the commonest STI
noted. Among the sexually transmitted infections, genital ulceration is
associated with maximum seroconcordance rates. This is evidenced in various
studies. [108-112]
Among the 39 females who had sexually transmitted infections, 10
females had multiple venereal diseases. Among them,9 belong to HIV
positive seroconcordant group while 1 belong to HIV seropositive discordant
group. Bacterial vaginosis was found to be the most common sexually
transmitted infection (STI) in the female subjects. The presence of STI in both
males and females were significantly associated with HIV transmission.
Conclusion
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Conclusion
Majority of the couples in this study were HIV positive seroconcordant
(65%) and the remaining 35% were serodiscordant.
On analysing the epidemiological characters of the study population we
arrived at the following conclusions namely:
? Majority (75%) of the population were within the age group of 25-45
years. They were mostly urban inhabitants (68%) with low educational
status and belonged to low socioeconomic strata.
? High risk behaviours such as contacts with commercial sex workers
was more prevalent among the male population (84%) and  few(9%)
had history of contacts with homosexuals.
? Most of the index cases were male (92%) and the commonest reason
for HIV screening was other departmental referrals (68%) and the
commonest mode of acquisition of HIV was through heterosexual
contacts (90%).
On analysing the various risk factors and their role in HIV transmission
we concluded that:
? The presence of sexually transmitted infections in either the index case
or their partners was significantly associated with HIV transmission.
Among the sexually transmitted infections, genital ulcer disease had
the maximum risk (>90%) of HIV transmission.
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? The practise of anal intercourse, sex during menstruation and previous
venereal diseases in males were also significantly associated with HIV
transmission.
? Condom usage and circumcision had a significant role in decreasing
the transmission of HIV among couples.
? Other risk factors such as duration of marital contact and number of
sexual exposure per week were not significantly associated with HIV
transmission.
? Previous venereal diseases in females and ART therapy had no
significant role in HIV transmission.
? Most common sexually transmitted infection among the males were
genital ulcer diseases while among female it was bacterial vaginosis.
In summary the univariate analysis of the above risk factors suggested
that HIV concordance was significantly associated with presence of sexually
transmitted infections, previous venereal diseases in males, anal intercourse,
and sexual contact during menstruation, avoidance of condom during sexual
act and lack of circumcision. Duration and frequency of sexual contact with
partner, previous venereal diseases in females and ART were found not to
influence the transmission of HIV.
Based on this study, it is necessary that the partners of HIV infected
persons are identified, counselled and offered HIV testing since they are at the
highest risk of acquiring HIV infection. Further high rates of co-occurring STI
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in people living with HIV/AIDS will impede the efforts taken to prevent HIV
transmission. Therefore aggressive behavioral interventions that include STI
screening and treatment of all sexually active HIV-infected persons becomes
imperative.
Limitations of the study
1. Since it was a cross sectional study there was difficulty in determining
the sequence of events. For example, some of the potential risk factors
for concordance may not have occurred before the partner was infected
with HIV.
2. Bias is another problem in this study. Data referring to previous years
may be affected by recall bias, and information on sexual practices and
drug use may additionally be affected by reporting bias.
3. The study had a small sample size and hence statistical analysis may
not be conclusive in some of the risk factors in relation to HIV
concordance.
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Proforma
PROFOMA :
Serial No. :
STD OP No  :
Name :
Sex                :
Age :
18-25
26-35
36-45
?46
Address :
Urban
Rural
Occupation :
Private Employee
Government Employee
Self Employee
Unemployed
Monthly Income:
<1000
1000-4000
>4000
Education Status:
Illiterate
<5th
6th – 12th
Graduate
Sexual History:
Married since < 5years
5-10 years
11-15 years
> 15 years
Premarital Contact yes   No
If yes                                                                    Commercial  sexworker
                                                                              Homosexual
                                                                               transgender
                                                                              Known person
Extra marital contact Yes No
If yes                                                                       commercial sexworker
                                                                                 Homosexual
                                                                                 Transgender
                                                                                 Known person
Number of sexual contact with partner / week ?1
                                                                                                      2-3
                                                                                                       ?4
Have practiced anal sex with partner                                  Never
                                                                                                    Ever
Have practiced oral sex with partner                                 Never
                                                                                                   Ever
Condom usage with partner
                             Always
                            Occasionally
                             Never
Circumcision done (Male)                   Yes No
Sex during menstruation                  Yes    No
Contraceptive followed                                                     Oral
                                                                                               IUD
                                                                                               Shield
                                                                                               Condom
                                                                                               No contraceptive
Previous history of sexually transmitted infection Yes No
If yes                                                                                            Genital ulcer
                                                                                                     Genital discharge
                                                                                                     Others
Presenting complaints
 Genital ulcer
 Genital discharge
Duration
Others if specify
H/O Itching over genitalia
H/O swelling in inguinal region
H/O burning micturition
H/O lower abdominal pain
H/O Dyspareunia
H/O oral lesion
IN FEMALES
Menstrual H/O
Obstetric H/O
Past history
TB, BA, any major illness.
H/O blood transfusions and any major surgeries.
Personal history
H/O alcohol intake
H/O smoking
H/O IV Drug abuse
General Examination
Pallor, Icterus, Cyanosis, Clubbing ,lymphadenopathy
Pulse rate, blood pressure
CVS
RS
CNS
P/A
Skin and mucous membrane
Genital Examination
Examination Inguinal lymphnode
External genitalia for any genital lesion
IN FEMALES
Speculum examination
Bi manual Examination
Master Chart
s.no relation Age u/r income edu
HIV
status
reason
HIV
ART
married
since
high risk sexual
behaviour
nos. sexual
contact/week
anal
sex
orals
sex
condom
usage
circumcission
sex during
menses
sexual
orientation
PVD sti c/d
1 H 3 U 2 3 R 2 N 4 1,2 1 N N 1 N N B 0 1,3 D
1 W 3 3 NR 4 N 0 0
2 H 3 R 2 2 R 2 N 3 1,2 3 N N 1 N N H 0 0 C
2 W 2 1 R 4 N 3 0
3 H 2 U 2 3 R 2 N 2 1 2 Y N 1 N Y H 1 3 C
3 W 2 3 R 4 N 0 8
4 H 4 U 2 3 R 2 Y 4 1,2 2 N N 1 N Y B 0 3,4 C
4 W 4 2 R 4 N 0 3,7
5 H 4 U 2 4 R 5 N 4 1,3 2 N N 1 N N H 0 0 C
5 W 4 3 R 4 N 0 0
6 H 3 U 2 3 R 5 N 3 D 2 N N 2 N N H 0 0 D
6 W 3 2 NR 4 N 0 0
7 H 3 R 2 3 NR 4 2 N 1 N N 1 Y N H 0 0 D
7 W 3 2 R 5 Y 1 0 0
8 H 2 U 1 3 NR 4 N 1 N 2 N N 1 N N H 0 0 D
8 W 2 1 R 5 1 0 0
9 H 3 R 1 2 R 5 N 3 1 2 N N 1 Y N H 0 0 D
9 W 3 1 NR 4 N 0 0
10 H 3 U 2 3 R 5 N 2 1 2 N N 1 N N H 0 0 D
10 W 3 3 NR 4 N 0 0
11 H 2 R 1 3 R 5 Y 1 1 2 N N 2 N N H 0 0 D
11 W 1 1 NR 4 N 0 0
12 H 3 U 2 3 R 5 Y 4 1 2 N N 2 N N H 0 0 D
12 W 3 3 NR 4 N 0 0
13 H 3 U 2 3 R 5 N 4 1 2 Y N 1 N Y H 0 0 C
13 W 3 3 R 4 N 0 10
14 H 3 R 1 2 R 1 N 4 1,3 2 Y N 1 N Y H 0 5 C
14 W 3 1 R 4 N 0 0
15 H 3 U 2 3 R 2 N 3 1 2 Y N 1 N Y H 0 2 C
15 W 3 3 R 4 N 0 0
MASTER  CHART
16 H 3 R 1 1 R 5 N 3 1,3 3 N N 1 N N H 0 5 C
16 W 3 1 R 4 N 0 10
17 H 3 U 2 2 R 5 N 4 1,2 2 Y N 2 N N B 0 0 C
17 W 3 1 R 4 N 0 7
18 H 3 U 2 3 R 1 N 1 1 2 N N 1 N N H 0 6 D
18 W 3 3 NR 4 N 0 0
19 H 2 U 2 3 R 5 N 2 1 2 N N 2 N N H 0 0 D
19 W 1 3 NR 4 N 0 0
20 H 3 U 2 2 R 5 N 2 1 1 N N 2 N N H 0 0 D
20 W 3 1 NR 4 N 0 0
21 H 3 U 2 3 R 5 N 2 1 2 N N 1 N N H 0 0 D
21 W 3 3 NR 4 N 0 0
22 H 3 U 2 3 R 1 N 3 1,2 2 N N 2 N N H 1 0 D
22 W 3 3 NR 4 N 0 0
23 H 2 U 2 3 NR 4 N 4 N 2 N N 1 N N H 0 1 D
23 W 2 3 R 2 3 3 1
24 H 3 R 2 3 R 2 N 3 2 1 N N 2 N N H 0 1,3 D
24 W 3 3 NR 4 N 0 0
25 H 3 U 2 4 R 5 N 1 D 2 N N 2 N N H 0 0 D
25 W 2 4 NR 4 N 0 0
26 H 3 R 1 2 R 5 N 2 1 2 N N 2 N N H 0 0 D
26 W 2 1 NR 4 N 0 0
27 H 2 U 2 3 R 5 N 3 2 2 N N 2 N N B 2 6 D
27 W 2 2 NR 4 N 0 0
28 H 4 U 2 3 R 5 N 3 1 2 N N 1 Y N H 0 0 D
28 W 4 2 NR 4 N 0 0
29 H 5 U 2 3 R 5 N 4 1 2 N N 2 N N H 0 0 C
29 W 4 3 R 4 N 0 0
30 H 5 U 2 2 NR 4 N 2 N 2 N N 1 N N H 0 0 D
30 W 4 1 R 5 3 0 0
31 H 4 U 2 3 R 2 N 3 1 2 Y N U N Y H 1 0 C
31 W 4 3 R 4 N 0 8
32 H 3 U 2 3 R 5 N 2 1,3 2 N N 1 N Y H 0 0 C
32 W 3 1 R 4 N 0 8,9,10
33 H 4 R 2 1 R 5 N 4 3 2 N N 1 N Y H 0 5 C
33 W 3 1 R 4 N 0 10
34 H 4 U 2 3 R 5 N 4 1 2 Y N 1 N Y H 0 0 C
34 W 3 3 R 4 N 0 10
35 H 2 U 2 3 R 5 N 4 1 2 N N 1 N N H 0 0 C
35 W 2 3 R 4 N 0 10
36 H 2 R 1 3 R 5 N 3 1 3 N N 2 N Y H 0 6 C
36 W 2 3 R 4 N 0 0
37 H 5 U 3 4 R 5 Y 4 1 1 N N 2 N N H 0 6 D
37 W 4 4 NR 4 N 0 0
38 H 1 R 2 2 R 1 N 1 1 2 N N 2 N N H 0 7,8 D
38 W 1 1 NR 4 N 0 0
39 H 3 U 1 3 R 5 N 3 3 2 Y N 1 N Y H 0 5 C
39 W 3 3 R 4 N 0 8
40 H 4 U 1 3 R 5 Y 3 1 2 Y N 1 N N H 1 5 C
40 W 3 3 R 4 N 0 7
41 H 2 R 1 1 R 5 D 2 1 2 Y N 1 N Y H 1 6 C
41 W 2 1 R 4 N 0 7,8
42 H 2 U 2 3 R 4 N 2 1 3 Y N 1 Y N H 1 0 C
42 W 2 2 R 3 N 0 0
43 H 2 U 2 3 R 5 N 2 1 2 Y N 1 N Y H 2 0 C
43 W 2 3 R 4 N 0 8,9,10
44 H 3 R 1 1 NR 4 2 1 2 N N 1 N N H 0 0 D
44 W 2 1 R 2 N N 0 11
45 H 5 R 1 1 R 5 N 4 1 2 N N 1 N Y H 0 0 C
45 W 4 1 R 4 N 0 0
46 H 4 U 2 1 R 5 N 4 1 2 y N 1 N N H 0 5 C
46 W 3 1 R 4 N 0 0
47 H 3 U 2 3 R 5 N 4 1 2 Y N 1 N N H 0 4 C
47 W 2 3 R 4 N 0 0
48 H 2 U 1 3 R 2 N 1 1 2 Y N 1 N Y H 0 4 C
48 W 2 3 R 4 N 0 0
49 H 3 R 2 3 R 2 N 2 1 2 Y N 1 N Y H 1 4 C
49 W 3 2 R 4 N 0 0
50 H 4 U 2 3 R 5 Y 3 1 2 N N 1 N N H 4 0 C
50 W 2 3 R 4 N 0 0
51 H 2 U 1 3 R 1 N 1 1 1 N N 2 N N B 0 5 D
51 W 2 2 NR 4 N 0 0
52 H 5 U 2 1 NR 4 4 1 1 N N 1 N N H 0 0 D
52 W 4 1 R 5 N N 0 8
53 H 4 U 2 3 R 5 N 4 1 2 N N 1 N N H 0 5 C
53 W 3 2 R 4 N 3 0
54 H 2 R 2 3 R 5 N 3 1 3 Y N 1 N N H 0 0 C
54 W 2 3 R 4 N 0 0
55 H 2 R 2 3 R 2 N 1 1 2 Y N 1 N Y H 0 3 C
55 W 2 1 R 4 N 0 0
56 H 2 U 1 3 R 2 N 2 1 2 Y N 1 N Y H 1 1,4 C
56 W 2 3 R 4 N 0 1
57 H 3 U 1 1 R 5 N 4 1 2 N N 1 N N H 0 0 D
57 W 3 1 NR 4 N 0 0
58 H 4 U 2 3 R 2 N 4 1 3 Y N 1 N N H 0 4,6 C
58 W 3 3 R 4 N 0 0
59 H 3 U 2 2 R 5 N 2 3 2 Y N 2 N Y H 1 0 C
59 W 3 1 R 4 N 0 0
60 H 4 U 1 2 R 1 N 4 3 2 Y N 1 N Y H 0 13 C
60 W 3 1 R 4 N 0 1,9
61 H 5 U 2 3 R 5 N 3 1 2 Y N 1 N Y H 0 0 C
61 W 3 3 R 4 N 0 8
62 H 3 U 2 2 R 5 N 2 1 1 Y N 1 N Y H 0 5 C
62 W 2 2 R 4 N 0 7
63 H 2 R 1 2 R 2 N 1 1 2 Y N 1 N N B 0 2 C
63 W 1 1 R 4 N 0 2,7
64 H 3 U 1 3 R 5 Y 2 1 2 N N 1 N N H 0 0 C
64 W 3 1 R 4 N 0 4
65 H 4 U 2 3 R 2 N 4 3,2 3 Y N 1 N N B 1 1,4 C
65 W 3 3 R 4 N 0 1
66 H 3 R 2 3 R 2 N 3 1 2 Y N 1 N N H 0 2 C
66 W 2 1 R 4 N 0 0
67 H 4 U 2 2 R 5 N 4 1 2 Y N 1 N Y H 0 0 C
67 W 3 1 R 4 N 0 8
68 H 3 R 1 1 R 5 N 3 1 2 Y N U N Y H 0 0 C
68 W 2 1 R 4 N 0 4
69 H 4 U 2 3 R 5 N 4 1 1 Y N U N Y H 1 0 C
69 W 3 1 R 4 N 3 0
70 H 2 U 2 4 R 5 Y 1 N 2 N N 2 N N H 0 0 C
70 W 2 4 R 4 N 0 0
71 H 3 U 2 2 R 5 N 3 1 2 Y N 1 N Y H 1 0 C
71 W 3 1 R 4 N 0 4
72 H 2 U 2 2 R 5 N 2 1 2 Y N 1 N Y H 0 0 C
72 W 2 2 R 4 N 0 9,8
73 H 3 R 1 1 R 5 N 4 1 2 Y N 1 N N H 0 5 C
73 W 2 1 R 4 N 0 10
74 H 3 U 2 3 R 5 N 3 1 2 N N 1 N Y H 0 0 C
74 W 2 3 R 4 N 0 8,9
75 H 3 R 2 2 R 5 N 1 1 2 Y N 1 N Y H 0 0 C
75 W 3 2 R 4 N 0 4
76 H 2 U 1 3 R 5 N 1 1 2 N N 1 N N H 0 0 C
76 W 1 3 R 4 N 0 8,9
77 H 2 U 2 3 R 4 N 1 1 2 Y N 1 N Y H 0 0 C
77 W 1 3 R 3 N 0 0
78 H 2 U 2 2 R 4 N 1 1 3 Y N 1 N Y H 1 1 C
78 W 1 3 R 3 N 1 1
79 H 2 R 2 1 R 5 N 2 1 3 Y N 1 N N H 1 1 C
79 W 1 1 R 4 N 0 1
80 H 3 U 2 3 R 5 Y 3 1 2 N N 2 N N H 1 0 D
80 W 2 3 NR 4 N 0 0
81 H 3 U 2 3 R 1 N 4 1 2 N N 2 N N H 0 0 D
81 W 2 1 NR 4 N 0 0
82 H 2 R 1 1 R 5 N 2 3 3 N N 1 N Y H 0 0 C
82 W 2 1 R 4 N 0 0
83 H 2 U 2 1 R 1 N 1 1 3 N N 1 Y N H 0 0 D
83 W 1 3 NR 4 N 0 0
84 H 2 R 1 2 R 5 D 1 1 2 Y N 1 N Y H 1 0 C
84 W 1 1 R 4 N 0 0
85 H 3 U 1 2 R 5 N 2 1 2 N N 1 N N H 1 3 C
85 W 2 1 R 4 N 0 0
86 H 3 R 1 3 NR 5 N 3 1 1 N N 1 N N B 0 3 D
86 W 3 2 R 4 N 0 0
87 H 4 R 1 1 R 5 N 4 1 1 N N 1 N N H 0 0 C
87 W 4 1 R 4 N 0 7
88 H 2 U 2 3 R 2 N 2 1 3 Y N 1 N Y H 0 1,4 C
88 W 2 2 R 4 N 0 1
89 H 2 U 2 1 R 1 N 1 1 1 N N 1 Y N H 0 0 D
89 W 2 1 NR 4 N 0 0
90 H 4 U 1 3 R 5 Y 4 1 2 N N 1 N N H 1 2 C
90 W 3 1 R 4 N 0 0
91 H 4 R 2 2 R 5 N 2 3 2 N N 1 N N H 0 2 C
91 W 3 2 R 4 N 0 0
92 H 3 U 1 3 R 5 Y 2 1 2 N N 2 Y Y H 0 0 D
92 W 2 3 NR 4 N 0 0
93 H 3 U 2 2 R 5 N 2 1 2 N N 1 N N H 0 0 D
93 W 2 2 NR 4 3 0 0
94 H 3 U 2 3 R 5 N 1 1 2 Y N 2 N N H 0 0 D
94 W 2 3 NR 4 N 0 0
95 H 3 U 1 2 R 2 N 1 1 2 Y N 1 N Y H 0 2 C
95 W 2 1 R 4 N 0 8
96 H 4 R 1 1 R 5 N 2 3 2 N N 1 N Y H 0 0 C
96 W 3 1 R 4 N 0 0
97 H 3 U 2 3 R 5 N 2 1 2 N N 1 N N H 0 6 C
97 W 1 2 R 4 N 0 0
98 H 3 R 2 3 NR 4 N 2 3 3 N N 2 N N H 0 7 D
98 W 1 3 R 5 3 0 7
99 H 2 R 1 2 R 1 N 2 1 2 N N 1 N N H 0 0 C
99 W 1 1 R 4 N 0 0
100 H 3 R 1 2 R 5 N 2 1 2 N N 1 N y H 0 3 C
100 W 1 2 R 4 N 0 9
H=husband Age Address Monthly income
W=wife 1 18-25 U -urban 1- <2000
2 26-35 r-rural 2-2000 to 5000
3 36-45 3->5000
4 46-55
5 >=56
education status Married since sex during menses ART=anti retroviral therapy
1 - illiterate <5 years 0=no 0=not on ART
2 - < 5th 5-10years 1=yes 1=on ART
3 - 6th to 12th 11-15 years
4 - graduate >15 years anal sex
Condom 0= no
Serostatus 1=yes
1 never C-Seroconcordance
2 occasionalD -Serodiscordance
3 always STIs
1 - VDRL reactivity
PVDs 2 - herpes
high risk sexual behaviour 1 - genital ulcer 3 - anogenital wart
1 - commercial sex work 2 - urethritis 4 - nonspecific genital ulceration
2 - homosexual 3 - vaginal discharge 5 - non specific urethritis
3 - known person 4 - balanophosthitis 6 - balanoposthitis
7 - vulvovaginal candidiasis
reason for HIV screening 8 - bacterial vaginosis
1 - high risk behaviour 9 - trichomonas vaginalis
2 - presence of STIs 10 - cervicitis
3 - maternal screening 11 - bartholin abscess
4 - spouse  HIV positive
5 - refer from other department

